Balyasny Asset Management
HSTO

Balyasny Asset Management’s Histogen Inc. Common Stock HSTO Stock Holding History

Balyasny Asset Management’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-149
Closed -$137K – 2439
2017
Q4 		$137K Buy
+149
New +$138K ﹤0.01% 1956

Other funds holding HSTO

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

Balyasny Asset Management's HSTO Position: Q1 2018 in Review

Balyasny Asset Management sold out of Histogen Inc. Common Stock (HSTO) in Q1 2018, closing a stake of 149 shares — an estimated $137K sold.

Balyasny Asset Management first reported a position in HSTO in Q4 2017 and held it in 1 quarter. The position peaked at $137K in Q4 2017. 73 funds tracked by Wall St. Rank hold HSTO as of Q1 2018.

  • Balyasny Asset Management reported no remaining Histogen Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Balyasny Asset Management sold 149 Histogen Inc. Common Stock shares in Q1 2018, an estimated $137K.
  • Balyasny Asset Management first reported a position in Histogen Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • Balyasny Asset Management's Histogen Inc. Common Stock position peaked at $137K in Q4 2017.
  • 73 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q1 2018.

Based on Balyasny Asset Management's 13F filing for Q1 2018, filed 15 May 2018.